SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Salma M. Wakil, Dorota M. Monies, Mohamed Abouelhoda, Nada Al-Tassan, Haya Al-Dusery, Ewa A. Naim, Banan Al-Younes, Jameela Shinwari, Futwan A. Al-Mohanna, Brian F. Meyer, Sulaiman Al-Mayouf, Association of a Mutation in LACC1 With a Monogenic Form of Systemic Juvenile Idiopathic Arthritis, Arthritis & Rheumatology, 2015, 67, 1
  2. 2
    Mikhail M. Kostik, Margarita F. Dubko, Vera V. Masalova, Ludmila S. Snegireva, Tatyana L. Kornishina, Irina A. Chikova, Tatyana S. Likhacheva, Eugenia A. Isupova, Natalia I. Glebova, Ekaterina M. Kuchinskaya, Eugenia V. Balbotkina, Natalia V. Buchinskaya, Olga V. Kalashnikova, Vyacheslav G. Chasnyk, Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis, Seminars in Arthritis and Rheumatism, 2015, 44, 4, 417

    CrossRef

  3. 3
    Grant S. Schulert, Alexei A. Grom, Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine- Directed Therapies, Annual Review of Medicine, 2015, 66, 1, 145

    CrossRef

  4. 4
    Linda Rossi-Semerano, Bruno Fautrel, Daniel Wendling, Eric Hachulla, Caroline Galeotti, Luca Semerano, Isabelle Touitou, Isabelle Koné-Paut, Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey, Orphanet Journal of Rare Diseases, 2015, 10, 1

    CrossRef

  5. 5
    Alessandro Consolaro, Giulia C. Varnier, Alberto Martini, Angelo Ravelli, Advances in biomarkers for paediatric rheumatic diseases, Nature Reviews Rheumatology, 2014,

    CrossRef

  6. 6
    Colleen K. Correll, Bryce A. Binstadt, Advances in the pathogenesis and treatment of systemic juvenile idiopathic arthritis, Pediatric Research, 2014, 75, 1-2, 176

    CrossRef

  7. 7
    Nanguneri Nirmala, Alexei Grom, Hermann Gram, Biomarkers in systemic juvenile idiopathic arthritis, Current Opinion in Rheumatology, 2014, 26, 5, 543

    CrossRef

  8. 8
    L. Galicier, Ce qu’il faut savoir sur le syndrome d’activation macrophagique en soins intensifs, Réanimation, 2014, 23, S2, 482

    CrossRef

  9. 9
    Francesca Minoia, Sergio Davì, AnnaCarin Horne, Erkan Demirkaya, Francesca Bovis, Caifeng Li, Kai Lehmberg, Sheila Weitzman, Antonella Insalaco, Carine Wouters, Susan Shenoi, Graciela Espada, Seza Ozen, Jordi Anton, Raju Khubchandani, Ricardo Russo, Priyankar Pal, Ozgur Kasapcopur, Paivi Miettunen, Despoina Maritsi, Rosa Merino, Bita Shakoory, Maria Alessio, Vyacheslav Chasnyk, Helga Sanner, Yi-Jin Gao, Zeng Huasong, Toshiyuki Kitoh, Tadej Avcin, Michel Fischbach, Michael Frosch, Alexei Grom, Adam Huber, Marija Jelusic, Sujata Sawhney, Yosef Uziel, Nicolino Ruperto, Alberto Martini, Randy Q. Cron, Angelo Ravelli, Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients, Arthritis & Rheumatology, 2014, 66, 11
  10. 10
    Mingce Zhang, Edward M. Behrens, T. Prescott Atkinson, Bita Shakoory, Alexei A. Grom, Randy Q. Cron, Genetic Defects in Cytolysis in Macrophage Activation Syndrome, Current Rheumatology Reports, 2014, 16, 9

    CrossRef

  11. 11
    Petros Efthimiou, Sabeeda Kadavath, Bella Mehta, Life-threatening complications of adult-onset Still’s disease, Clinical Rheumatology, 2014, 33, 3, 305

    CrossRef

  12. 12
    Grant S. Schulert, Alexei A. Grom, Macrophage activation syndrome and cytokine-directed therapies, Best Practice & Research Clinical Rheumatology, 2014, 28, 2, 277

    CrossRef

  13. 13
    Sebastiaan J. Vastert, Berent J. Prakken, Paediatric rheumatic disease: Diagnosing macrophage activation syndrome in systemic JIA, Nature Reviews Rheumatology, 2014, 10, 11, 640

    CrossRef

  14. 14
    Sergio Davì, Francesca Minoia, Angela Pistorio, AnnaCarin Horne, Alessandro Consolaro, Silvia Rosina, Francesca Bovis, Rolando Cimaz, Maria Luz Gamir, Norman T. Ilowite, Isabelle Kone-Paut, Sheila Knupp Feitosa de Oliveira, Deborah McCurdy, Clovis Artur Silva, Flavio Sztajnbok, Elena Tsitsami, Erbil Unsal, Jennifer E. Weiss, Nico Wulffraat, Mario Abinun, Amita Aggarwal, Maria Teresa Apaz, Itziar Astigarraga, Fabrizia Corona, Ruben Cuttica, Gianfranco D'Angelo, Eli M. Eisenstein, Soad Hashad, Loredana Lepore, Velma Mulaosmanovic, Susan Nielsen, Sampath Prahalad, Donato Rigante, Valda Stanevicha, Gary Sterba, Gordana Susic, Syuji Takei, Ralf Trauzeddel, Mabruka Zletni, Nicolino Ruperto, Alberto Martini, Randy Q. Cron, Angelo Ravelli, Performance of Current Guidelines for Diagnosis of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis, Arthritis & Rheumatology, 2014, 66, 10
  15. 15
    S. Colafrancesco, R. Priori, C. Alessandri, E. Astorri, C. Perricone, M. Blank, N. Agmon-Levin, Y. Shoenfeld, G. Valesini, sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia, Immunologic Research, 2014, 60, 2-3, 177

    CrossRef

  16. 16
    A. Dige, S. Støy, K. L. Thomsen, C. L. Hvas, J. Agnholt, J. F. Dahlerup, H. J. Møller, H. Grønbæk, Soluble CD163, a Specific Macrophage Activation Marker, is Decreased by Anti-TNF-α Antibody Treatment in Active Inflammatory Bowel Disease, Scandinavian Journal of Immunology, 2014, 80, 6
  17. 17
    Vishnu V. Reddy, Arpita Myles, Satyanaryan S. Cheekatla, Sushma Singh, Amita Aggarwal, Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis, International Journal of Rheumatic Diseases, 2014, 17, 3
  18. 18
    James Lee, B. French, T. Morgan, Samuel W. French, The liver is populated by a broad spectrum of markers for macrophages. In alcoholic hepatitis the macrophages are M1 and M2, Experimental and Molecular Pathology, 2014, 96, 1, 118

    CrossRef

  19. 19
    Stephan Ehl, Geneviève de Saint Basile, Stiehm's Immune Deficiencies, 2014,

    CrossRef

  20. 20
    G. Naheed Usmani, Bruce A. Woda, Peter E. Newburger, Advances in understanding the pathogenesis of HLH, British Journal of Haematology, 2013, 161, 5
  21. 21
    R. Knevel, D. P. C. Rooy, A. Zhernakova, G. Gröndal, A. Krabben, K. Steinsson, C. Wijmenga, G. Cavet, R. E. M. Toes, T. W. J. Huizinga, P. K. Gregersen, A. H. M. Helm-van Mil, Association of Variants in IL2RA With Progression of Joint Destruction in Rheumatoid Arthritis, Arthritis & Rheumatism, 2013, 65, 7
  22. 22
    Anders Etzerodt, Søren K. Moestrup, CD163 and Inflammation: Biological, Diagnostic, and Therapeutic Aspects, Antioxidants & Redox Signaling, 2013, 18, 17, 2352

    CrossRef

  23. 23
    Catherine Ingels, Holger J. Møller, Troels K. Hansen, Pieter J. Wouters, Ilse Vanhorebeek, Greet Van den Berghe, Circulating Levels of the Shed Scavenger Receptor sCD163 and Association with Outcome of Critically Ill Patients, Journal of Clinical Immunology, 2013, 33, 3, 619

    CrossRef

  24. 24
    Kai Lehmberg, Stephan Ehl, Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis, British Journal of Haematology, 2013, 160, 3
  25. 25
    Kai Lehmberg, Isabell Pink, Christine Eulenburg, Karin Beutel, Andrea Maul-Pavicic, Gritta Janka, Differentiating Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis from Other Forms of Hemophagocytic Lymphohistiocytosis, The Journal of Pediatrics, 2013, 162, 6, 1245

    CrossRef

  26. 26
    Shanmuganathan Chandrakasan, Alexandra H. Filipovich, Hemophagocytic Lymphohistiocytosis: Advances in Pathophysiology, Diagnosis, and Treatment, The Journal of Pediatrics, 2013, 163, 5, 1253

    CrossRef

  27. 27
    Oshrat E. Tayer-Shifman, Eldad Ben-Chetrit, Refractory macrophage activation syndrome in a patient with SLE and APLA syndrome – Successful use of PET- CT and Anakinra in its diagnosis and treatment, Modern Rheumatology, 2013, 1

    CrossRef

  28. 28
    Shunji Hasegawa, Takeshi Matsushige, Hirofumi Inoue, Midori Takahara, Madoka Kajimoto, Hiroshi Momonaka, Chiemi Ishida, Saya Tanaka, Tsuneo Morishima, Takashi Ichiyama, Serum soluble CD163 levels in patients with influenza-associated encephalopathy, Brain and Development, 2013, 35, 7, 626

    CrossRef

  29. 29
    Kuninobu Wakabayashi, Shigeko Inokuma, Erika Matsubara, Kae Onishi, Hiromitsu Asashima, Shinichiro Nakachi, Kiyofumi Hagiwara, Serum β2-microglobulin level is a useful indicator of disease activity and hemophagocytic syndrome complication in systemic lupus erythematosus and adult-onset Still’s disease, Clinical Rheumatology, 2013, 32, 7, 999

    CrossRef

  30. 30
    Antonio Pérez-Martínez, Síndromes hemofagocíticos (II): diagnóstico y tratamiento, Anales de Pediatría Continuada, 2013, 11, 5, 245

    CrossRef

  31. 31
    Shinjiro Kaieda, Naomi Yoshida, Fumiya Yamashita, Masaki Okamoto, Hiroaki Ida, Tomoaki Hoshino, Takaaki Fukuda, Successful treatment of macrophage activation syndrome in a patient with dermatomyositis by combination with immunosuppressive therapy and plasmapheresis, Modern Rheumatology, 2013, 1

    CrossRef

  32. You have free access to this content32
    W. Fries, M. Cottone, A. Cascio, Systematic review: macrophage activation syndrome in inflammatory bowel disease, Alimentary Pharmacology & Therapeutics, 2013, 37, 11
  33. 33
    Matthias Bartneck, Karl-Heinz Heffels, Manfred Bovi, Jürgen Groll, Gabriele Zwadlo-Klarwasser, The role of substrate morphology for the cytokine release profile of immature human primary macrophages, Materials Science and Engineering: C, 2013, 33, 8, 5109

    CrossRef

  34. 34
    Lucy R. Wedderburn, Kiran Nistala, Kelley's Textbook of Rheumatology, 2013,

    CrossRef

  35. 35
    Joyce J. Hsu, Tzielan Chang Lee, Christy I. Sandborg, Kelley's Textbook of Rheumatology, 2013,

    CrossRef

  36. 36
    Norman T Ilowite, Christy I Sandborg, Brian M Feldman, Alexi Grom, Laura E Schanberg, Edward H Giannini, Carol A Wallace, Rayfel Schneider, Kathleen Kenney, Beth Gottlieb, Philip J Hashkes, Lisa Imundo, Yukiko Kimura, Bianca Lang, Michael Miller, Diana Milojevic, Kathleen M O’Neil, Marilynn Punaro, Natasha Ruth, Nora G Singer, Richard K Vehe, James Verbsky, Amy Woodward, Lawrence Zemel, Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology, Pediatric Rheumatology, 2012, 10, 1, 31

    CrossRef

  37. 37
    Claudia Macaubas, Khoa D. Nguyen, Ariana Peck, Julia Buckingham, Chetan Deshpande, Elizabeth Wong, Heather C. Alexander, Sheng-Yung Chang, Ann Begovich, Yue Sun, Jane L. Park, Kuang-Hung Pan, Richard Lin, Chih-Jian Lih, Erin M. Augustine, Carolyn Phillips, Andreas V. Hadjinicolaou, Tzielan Lee, Elizabeth D. Mellins, Alternative activation in systemic juvenile idiopathic arthritis monocytes, Clinical Immunology, 2012, 142, 3, 362

    CrossRef

  38. 38
    Sharath Kumar, Divya Kunhiraman, Lalitha Rajam, Application of the Yamaguchi criteria for classification of “suspected” systemic juvenile idiopathic arthritis (sJIA), Pediatric Rheumatology, 2012, 10, 1, 40

    CrossRef

  39. 39
    Cheng-I Lin, Hsin-Hui Yu, Jyh-Hong Lee, Li-Chieh Wang, Yu-Tsan Lin, Yao-Hsu Yang, Bor-Luen Chiang, Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases, Clinical Rheumatology, 2012, 31, 8, 1223

    CrossRef

  40. 40
    Linda Rossi-Semerano, Isabelle Koné-Paut, Is Still's Disease an Autoinflammatory Syndrome?, International Journal of Inflammation, 2012, 2012, 1

    CrossRef

  41. 41
    Bianca Lattanzi, Sergio Davi, Silvia Rosina, Nicoletta Solari, Stefano Lanni, Giulia Bracciolini, Alberto Martini, Angelo Ravelli, Macrophage activation syndrome, Indian Journal of Rheumatology, 2012, 7, 1, 27

    CrossRef

  42. 42
    A Ravelli, A A Grom, E M Behrens, R Q Cron, Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment, Genes and Immunity, 2012, 13, 4, 289

    CrossRef

  43. 43
    Tellen D. Bennett, Mark Fluchel, Aimee O. Hersh, Kristen N. Hayward, Adam L. Hersh, Thomas V. Brogan, Rajendu Srivastava, Bryan L. Stone, E. Kent Korgenski, Michael B. Mundorff, T. Charles Casper, Susan L. Bratton, Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis, Arthritis & Rheumatism, 2012, 64, 12
  44. 44
    Surjit Singh, Shanmuganathan Chandrakasan, Jasmina Ahluwalia, Deepti Suri, Amit Rawat, Nishath Ahmed, Reena Das, M. U. S. Sachdeva, Neelam Varma, Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: clinical experience from northwest India, Rheumatology International, 2012, 32, 4, 881

    CrossRef

  45. 45
    Scott W. Canna, Edward M. Behrens, Making Sense of the Cytokine Storm: A Conceptual Framework for Understanding, Diagnosing, and Treating Hemophagocytic Syndromes, Pediatric Clinics of North America, 2012, 59, 2, 329

    CrossRef

  46. 46
    P. Lehmann, E. Huber, T. Dörner, M. Fleck, Makrophagenaktivierungssyndrom, Zeitschrift für Rheumatologie, 2012, 71, 8, 701

    CrossRef

  47. 47
    Jun Li, Hui-Chen Hsu, John D. Mountz, Managing Macrophages in Rheumatoid Arthritis by Reform or Removal, Current Rheumatology Reports, 2012, 14, 5, 445

    CrossRef

  48. 48
    Abdelali Tali, Amal Addebbous, Laila Zougaghi, Laila Chabaa, Pathogénie, intérêts diagnostique et pronostique de l’hypertriglycéridémie dans les lymphohistiocytoses hémophagocytaires, Revue Francophone des Laboratoires, 2012, 2012, 444, 75

    CrossRef

  49. 49
    Holger J. Møller, Soluble CD163, Scandinavian Journal of Clinical & Laboratory Investigation, 2012, 72, 1, 1

    CrossRef

  50. 50
    Keith A. Sikora, Ndate Fall, Sherry Thornton, Alexei A. Grom, The limited role of interferon-γ in systemic juvenile idiopathic arthritis cannot be explained by cellular hyporesponsiveness, Arthritis & Rheumatism, 2012, 64, 11
  51. 51
    Klinische Immunologie, 2012,

    CrossRef

  52. 52
    S. Weitzman, Approach to Hemophagocytic Syndromes, Hematology, 2011, 2011, 1, 178

    CrossRef

  53. 53
    Asami Maruyama, Naoto Takahashi, Yuji Gunji, Akira Morimoto, Yukari Yada, Yasunori Koike, Mariko Y. Momoi, Congenital Hemophagocytic Lymphohistiocytosis in a Preterm Infant, Journal of Pediatric Hematology/Oncology, 2011, 33, 5, e209

    CrossRef

  54. 54
    Theodore S. Johnson, Joyce Villanueva, Alexandra H. Filipovich, Rebecca A. Marsh, Jack J. Bleesing, Contemporary diagnostic methods for hemophagocytic lymphohistiocytic disorders, Journal of Immunological Methods, 2011, 364, 1-2, 1

    CrossRef

  55. 55
    Andrew I Shulman, Marilynn Punaro, Critical care of the pediatric patient with rheumatic disease, Current Opinion in Pediatrics, 2011, 23, 3, 263

    CrossRef

  56. 56
    C. Feighery, J. Dunne, E. A. Bingham, C. F. Feighery, Evaluation of soluble CD163 as a marker of inflammation in psoriasis, Clinical and Experimental Dermatology, 2011, 36, 2
  57. 57
    M. B. Jordan, C. E. Allen, S. Weitzman, A. H. Filipovich, K. L. McClain, How I treat hemophagocytic lymphohistiocytosis, Blood, 2011, 118, 15, 4041

    CrossRef

  58. 58
    Tomonari Shigemura, Takashi Yamazaki, Yosuke Hara, Jing-Ni Ou, Anne M Stevens, Hans D Ochs, Kenichi Koike, Kazunaga Agematsu, Monitoring serum IL-18 levels is useful for treatment of a patient with systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome, Pediatric Rheumatology, 2011, 9, 1, 15

    CrossRef

  59. 59
    Soie Chung, Ji-Eun Kim, Seungman Park, Kyou-Sup Han, Hyun Kyung Kim, Neutrophil and monocyte activation markers have prognostic impact in disseminated intravascular coagulation: In vitro effect of thrombin on monocyte CD163 shedding, Thrombosis Research, 2011, 127, 5, 450

    CrossRef

  60. 60
    Elizabeth D. Mellins, Claudia Macaubas, Alexei A. Grom, Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions, Nature Reviews Rheumatology, 2011, 7, 7, 416

    CrossRef

  61. 61
    Edward M. Behrens, Scott W. Canna, Katharine Slade, Sheila Rao, Portia A. Kreiger, Michele Paessler, Taku Kambayashi, Gary A. Koretzky, Repeated TLR9 stimulation results in macrophage activation syndrome–like disease in mice, Journal of Clinical Investigation, 2011, 121, 6, 2264

    CrossRef

  62. 62
    Yu-Tsan Lin, Chen-Ti Wang, M. Eric Gershwin, Bor-Luen Chiang, The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis, Autoimmunity Reviews, 2011, 10, 8, 482

    CrossRef

  63. 63
    Keith A. Sikora, Alexei A. Grom, Update on the pathogenesis and treatment of systemic idiopathic arthritis, Current Opinion in Pediatrics, 2011, 23, 6, 640

    CrossRef

  64. 64
    Alexei A. Grom, Textbook of Pediatric Rheumatology, 2011,

    CrossRef

  65. You have free access to this content65
    Bijal M. Mehta, Philip J. Hashkes, Robin Avery, Chad L. Deal, A 21-year-old man with Still's disease with fever, rash, and pancytopenia, Arthritis Care & Research, 2010, 62, 4
  66. 66
    M. Shimizu, T. Yokoyama, K. Yamada, H. Kaneda, H. Wada, T. Wada, T. Toma, K. Ohta, Y. Kasahara, A. Yachie, Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis, Rheumatology, 2010, 49, 9, 1645

    CrossRef

  67. 67
    Marianne Jensby Nielsen, Holger Jon Møller, Søren Kragh Moestrup, Hemoglobin and Heme Scavenger Receptors, Antioxidants & Redox Signaling, 2010, 12, 2, 261

    CrossRef

  68. 68
    Alexandra Filipovich, Kenneth McClain, Alexei Grom, Histiocytic Disorders: Recent Insights into Pathophysiology and Practical Guidelines, Biology of Blood and Marrow Transplantation, 2010, 16, 1, S82

    CrossRef

  69. 69
    Alexei A Grom, Elizabeth D Mellins, Macrophage activation syndrome: advances towards understanding pathogenesis, Current Opinion in Rheumatology, 2010, 22, 5, 561

    CrossRef

  70. 70
    Shivani Srivastava, Claudia Macaubas, Chetan Deshpande, Heather C. Alexander, Sheng-Yung Chang, Yue Sun, Jane L. Park, Tzielan Lee, Ann Begovich, Elizabeth D. Mellins, Monocytes are resistant to apoptosis in systemic juvenile idiopathic arthritis, Clinical Immunology, 2010, 136, 2, 257

    CrossRef

  71. 71
    Sumit Gupta, Sheila Weitzman, Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy, Expert Review of Clinical Immunology, 2010, 6, 1, 137

    CrossRef

  72. 72
    Margalit E. Rosenkranz, David C. Wilson, Anthony D. Marinov, Alisha Decewicz, Patrick Grof-Tisza, David Kirchner, Brendan Giles, Paul R. Reynolds, Michael N. Liebman, V. S. Kumar Kolli, Susan D. Thompson, Raphael Hirsch, Synovial fluid proteins differentiate between the subtypes of juvenile idiopathic arthritis, Arthritis & Rheumatism, 2010, 62, 6
  73. 73
    Abha A. Gupta, Pascal Tyrrell, Rahim Valani, Susanne Benseler, Mohamed Abdelhaleem, Sheila Weitzman, Experience With Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome at a Single Institution, Journal of Pediatric Hematology/Oncology, 2009, 31, 2, 81

    CrossRef

  74. 74
    Alessandro Parodi, Sergio Davì, Alejandra Beatriz Pringe, Angela Pistorio, Nicolino Ruperto, Silvia Magni-Manzoni, Paivi Miettunen, Brigitte Bader-Meunier, Graciela Espada, Gary Sterba, Seza Ozen, Dowain Wright, Claudia Saad Magalhães, Raju Khubchandani, Hartmut Michels, Patricia Woo, Antonio Iglesias, Dinara Guseinova, Claudia Bracaglia, Kristen Hayward, Carine Wouters, Alexei Grom, Marina Vivarelli, Alberto Fischer, Luciana Breda, Alberto Martini, Angelo Ravelli, Macrophage activation syndrome in juvenile systemic lupus erythematosus: A multinational multicenter study of thirty-eight patients, Arthritis & Rheumatism, 2009, 60, 11
  75. 75
    Andreea Coca, Kemp W. Bundy, Bethany Marston, Jennifer Huggins, R. John Looney, Macrophage activation syndrome: Serological markers and treatment with anti-thymocyte globulin, Clinical Immunology, 2009, 132, 1, 10

    CrossRef

  76. 76
    Leticia Castillo, Joseph Carcillo, Secondary hemophagocytic lymphohistiocytosis and severe sepsis/systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation, Pediatric Critical Care Medicine, 2009, 10, 3, 387

    CrossRef

  77. 77
    Sebastiaan J. Vastert, Wietse Kuis, Alexei A. Grom, Systemic JIA: new developments in the understanding of the pathophysiology and therapy, Best Practice & Research Clinical Rheumatology, 2009, 23, 5, 655

    CrossRef

  78. 78
    Alison Kelly, Athimalaipet V Ramanan, A case of macrophage activation syndrome successfully treated with anakinra, Nature Clinical Practice Rheumatology, 2008, 4, 11, 615

    CrossRef

  79. 79
    Kejian Zhang, Jennifer Biroschak, David N. Glass, Susan D. Thompson, Terri Finkel, Murray H. Passo, Bryce A. Binstadt, Alexandra Filipovich, Alexei A. Grom, Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms, Arthritis & Rheumatism, 2008, 58, 9
  80. 80
    Edward M. Behrens, Macrophage activation syndrome in rheumatic disease: What is the role of the antigen presenting cell?, Autoimmunity Reviews, 2008, 7, 4, 305

    CrossRef

  81. 81
    S. C. Li, Presenting Features of Systemic Onset JRA, AAP Grand Rounds, 2008, 20, 1, 8

    CrossRef

  82. 82
    J. García-Consuegra Molina, R. Merino Muñoz, J. de Inocencio Arocena, Síndrome de activación macrofágica y artritis idiopática juvenil. Resultados de un estudio multicéntrico, Anales de Pediatría, 2008, 68, 2, 110

    CrossRef

  83. 83
    Ndate Fall, Michael Barnes, Sherry Thornton, Lorie Luyrink, Judyann Olson, Norman T. Ilowite, Beth S. Gottlieb, Thomas Griffin, David D. Sherry, Susan Thompson, David N. Glass, Robert A. Colbert, Alexei A. Grom, Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome, Arthritis & Rheumatism, 2007, 56, 11
  84. 84
    Christopher E Lowe, Jason D Cooper, Todd Brusko, Neil M Walker, Deborah J Smyth, Rebecca Bailey, Kirsi Bourget, Vincent Plagnol, Sarah Field, Mark Atkinson, David G Clayton, Linda S Wicker, John A Todd, Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes, Nature Genetics, 2007, 39, 9, 1074

    CrossRef

  85. 85
    Bradley J. Bloom, Macrophage activation is a key component in the pathogenesis of systemic juvenile idiopathic arthritis: Comment on the article by Blessing et al, Arthritis & Rheumatism, 2007, 56, 11
  86. 86
    Potential markers for macrophage activation syndrome in systemic JIA, Nature Clinical Practice Rheumatology, 2007, 3, 6, 310

    CrossRef

  87. 87
    Babs O. Fabriek, Holger J. Møller, Rianka P.M. Vloet, Lisa M. van Winsen, Roeland Hanemaaijer, Charlotte E. Teunissen, Bernard M.J. Uitdehaag, Timo K. van den Berg, Christine D. Dijkstra, Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis, Journal of Neuroimmunology, 2007, 187, 1-2, 179

    CrossRef

  88. 88
    Alison Kelly, Athimalaipet V Ramanan, Recognition and management of macrophage activation syndrome in juvenile arthritis, Current Opinion in Rheumatology, 2007, 19, 5, 477

    CrossRef